The first patient, a woman in her 50s, received insulin and semaglutide for 4 days before a subcutaneous dose of semaglutide
Clinical Supervisor & Physician Associate at Transition Medical Weight Loss | Obesity Medicine Speaker & Writer The future of obesity medicine looks incredibly bright
TRIUMPH-1 (NCT05929066, n=2,339, 80 weeks, general obesity): 28.3% average weight loss on the 12mg dose
If you experience any changes in sexual health while taking semaglutide, its important to consult your healthcare provider for proper guidance
Yes, some people transition to a maintenance dose after reaching their goal weight
The 0.25mg starting dose differs from the 0.5mg week-five dose and the 1.0mg maintenance dose